New Therapies and Current Management of Lymphomas


Related Videos (117)

Stephen J. Schuster, MD, Director of the Lymphoma Program & Lymphoma Translational Research at the Abramson Cancer Center of the University of Pennsylvania, infuses this presentation with more than thirty years of insight from practice to offer a frank consideration of the clinical trials presented at ASH 2015 for the treatment of the non-Hodgkin, diffuse large B cell, mantle cell and follicular lymphomas. Highlights include optimistic outcomes from the Penn CTL019 T cell therapy study for relapsed/refractory CD19+ NHL, which included patients with NHL, follicular and mantle cell lymphomas.


Penn PhysicianLink®

Penn PhysicianLink® is an exclusive program that helps all referring physicians connect with Penn Medicine. This comprehensive package of support services expedites and facilitates direct physician communication for patient consults, referrals and transfers.

Learn more about Penn PhysicianLink®